ProfileGDS5822 / ILMN_2494618
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 90% 91% 91% 90% 90% 91% 89% 90% 91% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 151090
GSM1276600PDAC Late Ablation Control 2609.191
GSM1276601PDAC Late Ablation Control 3632.991
GSM1276602PDAC Late Ablation 1499.290
GSM1276603PDAC Late Ablation 2525.690
GSM1276604PDAC Late Ablation 3689.691
GSM1303940PDAC Late Ablation_anti-CTLA4 1424.789
GSM1303941PDAC Late Ablation_anti-CTLA4 2564.190
GSM1303942PDAC Late Ablation_anti-CTLA4 3685.591